【2h】

ACE2 alterations in kidney disease

机译:肾脏疾病中的ACE2改变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Angiotensin-converting enzyme 2 (ACE2) is a monocarboxypeptidase that degrades angiotensin (Ang) II to Ang-(1–7). ACE2 is highly expressed within the kidneys, it is largely localized in tubular epithelial cells and less prominently in glomerular epithelial cells and in the renal vasculature. ACE2 activity has been shown to be altered in diabetic kidney disease, hypertensive renal disease and in different models of kidney injury. There is often a dissociation between tubular and glomerular ACE2 expression, particularly in diabetic kidney disease where ACE2 expression is increased at the tubular level but decreased at the glomerular level. In this review, we will discuss alterations in circulating and renal ACE2 recently described in different renal pathologies and disease models as well as their possible significance.
机译:血管紧张素转换酶2(ACE2)是一种单羧肽酶,可将血管紧张素(Ang)II降解为Ang-(1-7)。 ACE2在肾脏中高度表达,它主要位于肾小管上皮细胞中,而在肾小球上皮细胞和肾脉管系统中则不那么突出。在糖尿病性肾脏疾病,高血压性肾脏疾病和不同形式的肾脏损伤中,ACE2活性已显示出改变。肾小管和肾小球ACE2表达之间通常存在分离,尤其是在糖尿病肾病中,其中肾小管水平ACE2表达增加但在肾小球水平降低。在这篇综述中,我们将讨论最近在不同的肾脏病理学和疾病模型中描述的循环和肾脏ACE2的改变及其可能的意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号